Precision Path:
Breast Cancer
Clinical decision support that translates your unique genomic profile and diagnosis into a clear, evidence-based treatment pathway — built by a physician-researcher who is also principal investigator on the FLEX registry generating the real-world data behind it.
The challenge
A breast cancer diagnosis immediately plunges patients into a world of unfamiliar complexity.
Overwhelming complexity
Treatment decisions depend on tumour subtype, staging, genomic profile, menopausal status, and dozens of other factors that interact in non-obvious ways.
Fragmented information
Genomic test results arrive as PDFs. Guidelines live in separate documents. Trial data is scattered across journals. Nothing is connected.
Time pressure
Clinicians have limited time to synthesize rapidly evolving evidence for each patient. Patients have even less time to understand their options.
One platform. Complete clarity.
Precision Path connects the dots between complex patient diagnoses, genomic profiles, and the latest clinical evidence — all in one place.
Structured Clinical Intake
Tumour characteristics, staging, receptor status, and genomic test results — everything systematically captured in a comprehensive clinical profile.
Real-Time Evidence Engine
The patient's profile is matched against NCCN 2026 guidelines, genomic signatures, and published clinical trial outcomes in real time.
Actionable Treatment Pathways
A structured, step-by-step treatment pathway with survival projections, benefit analyses, and side effect management — equipping care teams for shared decision-making.
Everything you need in one place
Genomic Profile Integration
Native integration with leading genomic risk assays and molecular subtyping platforms. Your genomic results directly influence pathway routing, ensuring treatment recommendations match your tumour's biological behavior. Informed by real-world data from the FLEX registry (published JNCI Cancer Spectrum, 2025).
Survival Projections
Kaplan-Meier survival curves personalized to your profile, showing 5-year and 10-year disease-free and overall survival projections.
NCCN-Aligned Pathways
Treatment pathways built on the latest NCCN 2026 guidelines, covering 19+ distinct clinical pathways and 107+ steps.
Treatment Benefit Analysis
Quantified benefit estimates for chemotherapy, endocrine therapy, targeted agents, and immunotherapy — with caveats where evidence is limited.
Integrative Medicine
Evidence-graded complementary therapies — yoga, acupuncture, mindfulness — integrated alongside conventional treatments with safety interactions noted.
Side Effect Tracking
Comprehensive side effect profiles for every treatment, with proactive management strategies and when to seek urgent care.
Decision support that respects your expertise
Precision Path isn't a replacement for clinical judgment — it's a tool that puts the latest evidence at your fingertips so you can focus on what matters most: your patient.
- Instant access to relevant NCCN pathways for each patient profile
- Published trial data synthesized into actionable benefit estimates
- FDA-level audit trails for every clinical recommendation
- Patient-facing companion app for shared decision-making
Extend the value of genomic testing
For genomic testing companies and pharmaceutical partners, Precision Path creates measurable downstream value from test results by driving treatment pathway adherence and patient engagement.
- Native integration with genomic test result APIs
- White-label and co-branded deployment options
- Clinical evidence demand driver for genomic testing adoption
- Scalable architecture ready for multi-cancer expansion
See Precision Path in action
Whether you're a patient looking for clarity, a clinician seeking better tools, or a partner exploring integration — we'd love to show you a demo.